Funding to support clinical development of ANN-101, a once-weekly GLP-1 patch for obesity, and expansion of the HeroPatch platform BOSTON--(BUSINESS WIRE)--Anodyne Nanotech Inc., a clinical-stage biotechnology company simplifying chronic care through transdermal delivery, today announced the closing of a $12.6 million Series A financing
However, this occurs independently of changes in metabolic parameters
Collectively, these results support HA + GSH-C4fortified lubricants as a promising therapeutic strategy for G-OSD
discloses support for the research of this work from the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/L021382/1), in part from the Medical Research Council (MRC) (MR/W005166/1), and Institutional Strategic Support Fund and the University of Oxford (ISSF-2019)
Med (Basel), 2018
Spend TV Impressions National Impressions Local Impressions There's a Better Way to Measure TV & Streaming Ad ROI Real-Time Ad Measurement Across Linear and CTV TV Ad Attribution & Benchmarking Marketing Stack Integrations and Multi-Touch Attribution Real-Time Video Ad Creative Assessment Get a Demo Today Check out LifeMD's 15 second TV commercial, 'Helping People Lose Weight: GLP-1 Medications' from the Medical Services industry